MHRA Outlines Regulatory Goals in Preparation for Leaving the EU

The U.K.’s Medicines and Healthcare products Regulatory Agency laid out its top 10 priorities for 2017 and 2018 — including developing a model for the agency’s future, post-Brexit.
Source: Drug Industry Daily